Live Breaking News & Updates on Fierce Biotech Homepage

Stay updated with breaking news from Fierce biotech homepage. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Enochian distances itself from co-founder amid short attack

Enochian Biosciences CEO Mark Dybul is pushing back against what he calls a “thinly veiled attempt to smear” the biotech’s reputation. ....

Enochian Biosciences , Criminal Case , Biotech Stock , Activist Investor , Fierce Biotech Homepage ,

FDA refuses to review Aeglea's rare disease drug application

The FDA has no plans to make a decision on whether Aeglea BioTherapeutics’ rare disease drug is approvable or not. ....

Aeglea Biotherapeutics , Rare Diseases , Da Refuse To File Letter , Fierce Biotech Homepage ,

Amgen's heart drug reduces cardiovascular disease risk factor

Amgen's olpasiran has been found to reduce levels of lipoprotein, or Lp(a), which is a risk factor for cardiovascular disease. ....

Cardiovascular Disease , Heart Disease , Heart Attack , Clinical Data , Fierce Biotech Homepage ,

Terremoto spells out covalent drug alphabet with $75M series A

Terremoto Biosciences will use $75 million in series A funding to broaden the covalent drug alphabet available to treat complex diseases. ....

Venture Capital Vc , Undruggable Targets , Third Rock Ventures , Covalent Bonds , Venture Capital , Fierce Biotech Homepage ,

Manufacturing concerns sideline INmune's US Alzheimer's trial

The FDA has blocked the small biotech INmune from moving an Alzheimer’s disease therapy into a phase 2 clinical study on manufacturing concerns. ....

Inmune Bio , Alzheimer 039s Disease , Clinical Hold , Food And Drug Administration Fda , Neurodegenerative Diseases , Inflammatory Conditions , Fierce Biotech Homepage ,